Jeremy A. Ryan

发表论文 279 篇 · 总被引 7912 次 · h-index 44

代表论文

Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms (2025 · Cell Death and Differentiation · 被引 4)
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML (2025 · Blood Advances · 被引 4)
Venetoclax plus inotuzumab ozogamicin for relapsed and refractory ALL: Results of a phase I trial (2025 · Blood · 被引 2)
Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML (2025 · Blood · 被引 1)
Supplementary Table 1 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine (2026)
Figure S2 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine (2026)